Clinical Trial Update: Avelumab Program Rollover Study [Phase 3]

View source ↗

Summary

This document provides a clinical trial update for the avelumab program rollover study (Phase 3). The trial is currently active but not recruiting in solid tumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• BAVENCIO (AVELUMAB)

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Solid Tumors | Phase 3 | Status: ACTIVE_NOT_RECRUITING